Does ESKETAMINE Cause Psychomotor hyperactivity? 16 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Psychomotor hyperactivity have been filed in association with ESKETAMINE (Spravato). This represents 0.1% of all adverse event reports for ESKETAMINE.
16
Reports of Psychomotor hyperactivity with ESKETAMINE
0.1%
of all ESKETAMINE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From ESKETAMINE?
Of the 16 reports, 2 (12.5%) required hospitalization.
Is Psychomotor hyperactivity Listed in the Official Label?
Yes, Psychomotor hyperactivity is listed as a known adverse reaction in the official FDA drug label for ESKETAMINE.
What Other Side Effects Does ESKETAMINE Cause?
Dissociation (3,103)
Sedation (2,244)
Suicidal ideation (1,254)
Drug ineffective (1,005)
Nausea (807)
Depression (800)
Anxiety (659)
Hospitalisation (657)
Product dose omission issue (635)
Hypertension (605)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which ESKETAMINE Alternatives Have Lower Psychomotor hyperactivity Risk?
ESKETAMINE vs ESLICARBAZEPINE
ESKETAMINE vs ESMOLOL
ESKETAMINE vs ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\NAPROXEN